Pre-Implantation Genetic Screening (PGS)
11 November 2016
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Name and Constituency of Member of Parliament
Mr Louis Ng Kok Kwang
MP for Nee Soon GRC
Question No. 638
To ask the Minister for Health considering that gender bias for Pre-Implantation Genetic Screening (PGS) can now be blinded, whether the Ministry will consider permitting women with recurrent miscarriages or a history of infertility to seek PGS in Singapore.
Name and Constituency of Member of Parliament
Miss Cheng Li Hui
MP for Tampines GRC
Question No. 715
To ask the Minister for Health whether the Ministry will consider permitting Pre-Implantation Genetic Screening to improve the chances of healthy live births, subject to strict controls such as banning sex selection and use for other non-medical reasons.
Oral Answer
1. MOH had previously received requests to allow PGS to identify chromosomal abnormalities in embryos created through in-vitro fertilization (IVF), with the aim of improving the chances of conceiving. We had not granted approval so far as the published evidence had been unclear. In recent years however, newer technologies for PGS have emerged and some jurisdictions have now allowed PGS.
2. MOH is therefore reviewing the clinical effectiveness of PGS and its ethical implications. To assess clinical effectiveness, NUH will be conducting a three-year pilot PGS programme which will commence by early next year.
3. MOH will also look into the ethical concerns and regulation of PGS. For example, we will need to ensure that embryos are not eliminated solely based on parental preferences on characteristics such as gender.
4. MOH will consult stakeholders and the public to gather views.